In vivo assays confirmed the promoting effects of DCDC2 on the tumorigenicity of ICC cells (Fig. 2C and D), with both increased tumor volumes and tumor weight. The gene discussed is DCDC2; the disease is intrahepatic cholangiocarcinoma.